FILE - This image provided by Eisai in January 2023 shows vials and packaging for their medication, Leqembi. Several health plans in the U.S. will not cover the recently approved Alzheimers drug ...

Some Alzheimer’s experts say the delay is likely too subtle for patients or their families to notice. READ MORE: A 2nd experimental Alzheimer’s drug shows promise, but comes with safety risks ...

Some veterans will be able to get help affording a new Alzheimer’s treatment. The VA said it will cover Lecanemab, also known as Leqembi, after it was given accelerated approval by the U.S. F… ...

Unless Medicare widely covers these drugs, they will be unaffordable for the vast majority of consumers and the market will dry up. For example, the most recent anti-Alzheimer’s drug to win FDA ...

Some private insurers are balking at paying for the first drug fully approved to slow mental decline in Alzheimer’s patients. Insurers selling coverage in North Carolina, Pennsylvania and New ...

Insurers selling coverage in North Carolina, Pennsylvania and New York, among other states, told The Associated Press they won’t cover Leqembi with insurance offered on the individual market and ...

Updated: 1:44 PM CDT Aug 11, 2023 By TOM MURPHY AP Health Writer Insurers won't cover new Alzheimer's treatment for some customers Updated: 1:44 PM CDT Aug 11, 2023 ...

Several health plans in the U.S. will not cover the recently approved Alzheimer’s drug for certain customers, exposing those patients to thousands of dollars in potential costs.